Ultragenyx Pharmaceutical Inc. (LON:0LIF)

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $166.50M USD in the quarter ending June 30, 2025, with 13.24% growth. This brings the company's revenue in the last twelve months to $610.16M, up 26.77% year-over-year. In the year 2024, Ultragenyx Pharmaceutical had annual revenue of $560.23M with 29.01% growth.

• Revenue (ttm): $610.16M
• Revenue Growth: +26.77%
• P/S Ratio: 4.42
• Revenue / Employee: $471.53K
• Employees: 1,294
• Market Cap: 1.97B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	560.23M	125.98M	29.01%
Dec 31, 2023	434.25M	70.92M	19.52%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%